Metabolism of Omega-3 and Omega-6 During Healthy Aging

NCT ID: NCT02957188

Last Updated: 2016-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

13 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-08-31

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the kinetics of 13C-eicosapentaenoic acid (EPA) and 13C-arachidonic acid (AA) in young and older participants

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Eicosapentaenoic acid Arachidonic acid Metabolism Healthy aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Young

Six young (18-30 yrs old) healthy participants were recruited. The study had three blocks of one month: 13C-EPA follow-up, wash-out and 13C-AA follow-up. Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.

13C eicosapentaenoic acid and 13C arachidonic acid

Intervention Type OTHER

Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.

Elderly

Six older (≥ 70 yrs old) healthy participants were recruited. The study had three blocks of one month: 13C-EPA follow-up, wash-out and 13C-AA follow-up. Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.

13C eicosapentaenoic acid and 13C arachidonic acid

Intervention Type OTHER

Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

13C eicosapentaenoic acid and 13C arachidonic acid

Each participant orally consumed a single oral dose of 35 mg of 13C-EPA, and after the wash-out, a 50 mg dose of 13C-AA.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* six young (18-30 y old) and six older (≥ 70 y old)
* healthy non medicated participants.

Exclusion Criteria

* Tobacco,
* malnutrition (assessed from blood albumin, haemoglobin and lipids), -
* participants taking an EPA+DHA supplements or consuming more than 2 fish meals per week,
* severe gastro-intestinal problems,
* medication for diabetes,
* thyroid disease,
* renal failure,
* cancer,
* psychiatric difficulties or depression,
* cardiovascular disease,
* glucose intolerance (\>8 mmol/L in fasted samples)
* chronic immune condition or inflammation (CRP \> 10 mg/l, white cell count),
* recent major surgery or cardiac event,
* dementia,
* ongoing or past severe drug or alcohol abuse,
* ongoing or past intensive physical training.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Healthy Aging Research Network

NETWORK

Sponsor Role collaborator

Université de Sherbrooke

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mélanie Plourde

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Leveille P, Chouinard-Watkins R, Windust A, Lawrence P, Cunnane SC, Brenna JT, Plourde M. Metabolism of uniformly labeled 13C-eicosapentaenoic acid and 13C-arachidonic acid in young and old men. Am J Clin Nutr. 2017 Aug;106(2):467-474. doi: 10.3945/ajcn.117.154708. Epub 2017 Jun 28.

Reference Type DERIVED
PMID: 28659301 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

13C EPA and 13C AA metabolism

Identifier Type: -

Identifier Source: org_study_id